Pulmonary Mucormycosis: What to Do When First-Line Antifungal Treatment Fails to Control the Infection
This protocol addresses the clinical situation in which first-line management of pulmonary mucormycosis has not produced an adequate imaging response, and salvage therapy is required. The goal shifts to achieving complete resolution of infection signs, symptoms, and imaging findings.
Previous Treatment — Why Escalation Is Triggered
First-line treatment combined early surgical debridement with immediate antifungal therapy, transitioning to oral agents on achieving at least stable disease. Escalation to this salvage protocol is indicated when imaging assessment — typically conducted weekly — fails to demonstrate even stable disease or partial response, signalling inadequate disease control.
Salvage Approach (Partial — Full Protocol Required)
Salvage management involves switching to an alternative antifungal drug class or escalating to a lipid-based formulation, with combination strategies considered in more severe cases. The complete algorithm — including agent selection, sequencing, and the criteria for combination — is available only in the full structured protocol.
Treatment Goal
Resolution of signs and symptoms of infection and complete response on imaging. Treatment continues until immunosuppression is permanently reversed and imaging confirms complete response — a determination that may be complicated by residual scarring or postoperative change.
References
- Isavuconazole is strongly supported as salvage treatment.
- Posaconazole delayed release tablets or infusions are strongly supported for salvage treatment, and when available should be preferred over posaconazole oral suspension, which in turn is marginally supported for salvage treatment.
- In cases of primary treatment failure with isavuconazole or posaconazole, the guideline group supports recommendations for all three lipid-based amphotericin B formulations with strong to moderate strength.
- In case of extensive disease, rapid progression, or poor general condition, the addition of isavuconazole or posaconazole can be considered.
- The guideline group strongly supports treatment until permanent reversal of immunosuppression and complete response on imaging, which might be difficult to determine because of scarring and postoperative changes.
View source ↗